Aducanumab: What about the Patient?

Ronald C. Petersen

doi:10.1002/ana.26181

Aducanumab: What about the Patient?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	334-335
Number of pages	2
Journal	Annals of neurology
Volume	90
Issue number	3
DOIs	https://doi.org/10.1002/ana.26181
State	Published - Sep 2021

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/ana.26181

Cite this

@article{cb5ed00c1bd84109acaa208c85d15dfe,

title = "Aducanumab: What about the Patient?",

author = "Petersen, {Ronald C.}",

note = "Funding Information: R.C.P. reports grants from the National Institute on Aging (U01 AG006786, P30 AG062677) and the Alzheimer's Association Zenith Award, and personal fees from Merck, Biogen, and Roche, and has served on a data monitoring committee for Genentech.",

year = "2021",

month = sep,

doi = "10.1002/ana.26181",

language = "English (US)",

volume = "90",

pages = "334--335",

journal = "Annals of neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Aducanumab

T2 - What about the Patient?

AU - Petersen, Ronald C.

N1 - Funding Information: R.C.P. reports grants from the National Institute on Aging (U01 AG006786, P30 AG062677) and the Alzheimer's Association Zenith Award, and personal fees from Merck, Biogen, and Roche, and has served on a data monitoring committee for Genentech.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85112671067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112671067&partnerID=8YFLogxK

U2 - 10.1002/ana.26181

DO - 10.1002/ana.26181

M3 - Editorial

C2 - 34322904

AN - SCOPUS:85112671067

SN - 0364-5134

VL - 90

SP - 334

EP - 335

JO - Annals of neurology

JF - Annals of neurology

IS - 3

ER -

Aducanumab: What about the Patient?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this